Delivery Order SPE2DB22D3016-SPE2DB25FBJM6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,525.70 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. IMFINZI is a specialized oncology pharmaceutical product, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $13,262.85 to AmerisourceBergen Drug Corp for the supply of IMFINZI (500 mg/10 mL vial, 10 mL). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a competitively awarded, non-set-aside procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. IMFINZI is an oncology medication used in cancer...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a ceiling value of $53,051.40 and a firm fixed price contract type. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $53,051.40 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 24, 2025, with performance occurring at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a $23,873.04 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 6, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award was made without a set-aside designation, reflecting open competition among qualified vendors. This delivery order...
- The Defense Logistics Agency awarded a $18,567.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of IMFINZI 500 mg/10 ml vials. The contract is a non-set-aside competitive award with a completion date of September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $15,915.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is to be completed by July 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,957.71 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of IMFINZI (an oncology medication) in 120 mg/2.4 mL vials with a ceiling value of $6,344.80. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $21,220.56 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJM6Delivery Order
The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $7,957.71 and an ultimate completion date of October 7, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor under this global contract vehicle, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and federal healthcare systems worldwide. The IMFINZI supply under this delivery order supports the Defense Health Agency and other federal healthcare customers' oncology treatment needs through DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 9/16/25 |